The Role of Galectin-1 and Galectin-3 in the Mucosal Immune Response to Citrobacter rodentium Infection by Curciarello, R et al.
The role of Galectin-1 and Galectin-3 in the mucosal immune response to
Citrobacter rodentium infection.
Curciarello, R; Steele, A; Cooper, D; MacDonald, TT; Kruidenier, L; Kudo, T
 
 
 
 
 
© 2014 Curciarello et al
CC-BY
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/18848
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
The Role of Galectin-1 and Galectin-3 in the Mucosal
Immune Response to Citrobacter rodentium Infection
Renata Curciarello1, Alison Steele1, Dianne Cooper2, Thomas T. MacDonald1*, Laurens Kruidenier1,
Takahiro Kudo1
1Centre for Immunology and Infectious Disease, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London,
United Kingdom, 2William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
Abstract
Despite their abundance at gastrointestinal sites, little is known about the role of galectins in gut immune responses. We
have therefore investigated the Citrobacter rodentium model of colonic infection and inflammation in Galectin-1 or Galectin-
3 null mice. Gal-3 null mice showed a slight delay in colonisation after inoculation with C. rodentium and a slight delay in
resolution of infection, associated with delayed T cell, macrophage and dendritic cell infiltration into the gut mucosa.
However, Gal-1 null mice also demonstrated reduced T cell and macrophage responses to infection. Despite the reduced T
cell and macrophage response in Gal-1 null mice, there was no effect on C. rodentium infection kinetics and pathology.
Overall, Gal-1 and Gal-3 play only a minor role in immunity to a gut bacterial pathogen.
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Introduction
Galectins are a family of 15 lectins, each containing a
carbohydrate recognition domain with affinity for b-galactoside-
containing oligosaccharides. Galectins show considerable func-
tional diversity and can alter immune cell function by acting as
both intracellular modulators and secreted effectors [1,2].
Galectin-3 (Gal-3) is highly expressed in the mucosal epithelium
and has pro-inflammatory functions, including immune cell
recruitment to, and maintenance at, inflammatory sites [3–5].
Gal-3 is a positive regulator of T cell proliferation, it can protect T
cells from apoptosis and can activate macrophage and neutrophil
phagocytosis and reactive oxygen species production [1,6–10]. In
addition, Lippert et al. found Gal-3 to be a potent stimulator of
colonic lamina propria fibroblasts, causing NF-kB activation and
IL-8 production [5].
Galectin-1 (Gal-1) is also highly expressed by colonic epithelial
cells but contrary to Gal-3 [11] it has mainly anti-inflammatory
functions, including the enhancement of regulatory T cell activity
and the inhibition of inflammatory cell recruitment to peripheral
sites [12–14]. In vivo studies support an anti-inflammatory role for
Gal-1, and Santucci et. al. showed that prophylactic or therapeutic
administration of Gal-1 can significantly reduce TNBS-induced
colitis by preventing T cell activation and pro-inflammatory
cytokine production[11]. Thus, Galectin-1 and Galectin-3 appear
to have opposing roles that may act in concert to regulate
inflammation and maintain immune homeostasis.
The in vivo role of Gal-1 and Gal-3 in mucosal immune
responses to bacterial infection has not been previously investi-
gated. Helicobacter pylori challenged human gastric epithelial cells
show increased expression of both Gal-1 and Gal-3 in vitro
[15,16], while in a mouse model of lung infection by Streptoccus
pneumoniae Gal-3 was found to be increased in infected lungs,
where it mediates neutrophil adhesion to endothelial cells and
neutrophil recruitment into tissues [17,18].
To determine the importance of Gal-1 and Gal-3 in immune-
mediated pathology and immunity to bacterial infection, we
infected Gal-1 or Gal-3 null mice with the non-invasive bacterial
pathogen Citrobacter rodentium. Infection of wild-type mice with
C. rodentium results in colitis and a Th1 biased mucosal
inflammatory response in the distal colon, providing a useful
model of mucosal immune responses [19].
Materials and Methods
Ethics statements
Experiments were performed in accordance with the Guidance
on the Operation of Animals, Scientific Procedures Act 1986, and
were approved by UK Home Office (Licence reference number:
PPL 70/6833). Queen Mary University of London is also a
signatory to the ARRIVE guidelines (Animal Research: Report In
Vivo Experiments) in the UK which seeks to provide the key
information on how an animal study was designed, conducted and
analysed. Anesthetized mice (intraperitoneal injection of 100 mg/
kg ketamine and 5 mg/kg xylacine) were humanely euthanised by
cervical dislocation by experienced research personnel. All efforts
were made to alleviate suffering during the whole experiment.
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Mice
Female 6–8 week old Gal-1 or Gal-3 deficient mice (Lgals12/2
and Lgals32/2, respectively) on a C57BL/6 background were
kindly provided by Prof. M. Perretti (William Harvey Research
Institute, Barts and The London, UK) from breeding colonies held
at B&K Universal Ltd (Hull, UK). Control C57BL/6 mice were
purchased from Charles River (Kent, UK). Animals were housed
in high efficiency particulate air filtered cages with sterile bedding
and free access to commercial food and water. Independent
infection experiments were performed at least twice using 3 to 6
mice per group. Animals were monitored daily. The license under
which these experiments were carried out allows animals to be
kept alive until they lose 10% of their body weight after which they
must be culled by a schedule 1 procedure. In this case, animals did
not lose weight during infection.
Bacteria and infections
The bacterial strain used in this study, Citrobacter rodentium
ICC180, was grown in Luria Bertani (LB) medium with 50 mg/ml
kanamycin at 37uC with agitation[20]. Mice were orally inocu-
lated with 200 ml of an overnight culture of bacteria resuspended
in 1 ml PBS (,56109 CFU) using a gavage needle. The viable
count of the inoculum was determined by retrospective plating
onto LB agar containing kanamycin. As it is outlined in figure 1A,
stool samples were recovered aseptically at various time points
after inoculation and the number of viable bacteria per gram of
stool was determined after homogenization at 0.1 g/ml in PBS
and plating onto LB agar containing kanamycin. At day 15 post
infection mice were sacrificed and pieces of distal colon were snap
frozen in liquid nitrogen before storage at270uC prior to analysis.
Hematoxylin and eosin staining of colonic sections
Frozen colonic tissues embedded in OCT mounting medium
(Agar Scientific Ltd., Stanstead, UK) were sectioned using a
cryostat to a thickness of 5 mm. Sections were mounted on
polylysine-coated slides (VWR BDH, Lutterworth, UK), they were
air dried overnight and then fixed in acetone for 20 min at room
temperature, before drying for a minimum of 1 hour. Sections
were then stained according to standard protocols for hematoxylin
and eosin staining. The colonic crypt length (as an indication of
hyperplasia) was measured using a graticule. Only well-oriented
crypts were measured and a minimum of 10 measurements were
taken for each sample.
Immunohistochemistry
Cryostat sections of acetone fixed mouse distal colon were
rehydrated in Tris-buffered saline (TBS) for 5 min and then
incubated for 1 hour with antibodies against CD3, CD4, CD8,
F4/80, and CD11c (AbD Serotec, Oxford, UK). Sections were
gently washed with TBS 3 times for 3 min before addition of
biotinylated anti-rat IgG (Abcam plc, Cambridge, UK) or anti-
hamster IgG (AbD Serotec, Oxford, UK) with 4% (v/v) normal
murine serum for blocking (Sera Laboratories International,
Sussex, UK) for 30 min at room temperature. After washing,
0.1% avidin-peroxidase conjugate (Sigma-Aldrich Ltd, Dorset,
UK) was added for 30 min before further washing and the
addition of diaminobenziadine substrate (Sigma-Aldrich Ltd,
Dorset, UK) for 5 to 10 min. The reaction was stopped with
excess TBS and sections were counterstained with hematoxylin. A
control slide using no primary antibody was used to show
endogenous peroxidase-containing cells. Stained cell populations
were counted in 5 randomly selected fields per section and data
were expressed as the number of positive cells per 250 mm2 of
colonic lamina propria.
Enzyme linked immunosorbent assay (ELISA)
Proteins were extracted from approximately 15 mg of snap
frozen colonic tissue by rapid rotor-stator homogenisation in PBS
plus protease inhibitor cocktail (SIGMA- Aldrich, St. Louis, MO,
USA), it was sonicated 3 times in 10 second bursts followed by
incubation in 1% Igepal lysis buffer for 20 min on ice with
occasional vortexing. Supernatants were analysed for cytokine
levels using a MesoScale Discovery mouse pro-inflammatory 7-
plex ELISA kit (Gaithersburg, MA, USA) and an SI6000 electro-
chemiluminescence plate reader, according to the manufacturer’s
instructions.
Migration assay
The murine monocytic cell line J774 [21], kindly provided by
Dr. Olivier Marches (Barts and The London School of Medicine
and Dentistry, London, UK), was maintained in DMEM
supplemented with 10% foetal bovine serum, 1% penicillin-
streptomycin and 25 mg/ml gentamycin at 37uC and 5% CO2
(Sigma-Aldrich Ltd., Dorset, UK). For migration assays, a 24 well
transwell plate containing 8.0 mm pore membrane inserts
(Appleton Woods, Birmingham, UK) was used. Top wells
contained 56104 J774 cells in 100 ml serum-free DMEM while
bottom wells contained 600 ml serum free DMEM plus 100 ng/ml
or 1 mg/ml recombinant mouse Gal-1 (R&D Systems, Abingdon,
UK). Recombinant mouse monocyte chemoattractant protein-1
(MCP-1) (R&D Systems, Abingdon, UK) at 100 ng/ml was used
as a positive control and media alone as a negative control.
Migration was allowed to proceed at 37uC and 5% CO2 for 6 to
24 hours after which adherent non-migratory cells were removed
from the insert with two PBS washes followed by gentle wiping
with a sterile cotton bud dipped in PBS. Migratory cells adhering
to the underside of the insert were fixed and stained using the
Hemacolor Rapid staining set (VWR BDH, Lutterworth, UK)
according to the manufacturer’s instructions. Cells were counted
by 2 independent researchers.
Statistics
Statistical analysis was carried out using GraphPad Prism 4
software. Data from experiments involving mice and their tissues
were analysed by means of a two-tailed Mann Whitney test for
non-parametric data, while the migration assay data were analysed
by ANOVA with Tukeys post test. A P value of ,0.05 was taken
as significant in all cases.
Results
In order to investigate the importance of Gal-1 and Gal-3 in
mucosal immune responses to infection, Lgals12/2 and Lgals32/2
mice were infected with the enteric pathogen Citrobacter rodentium.
Bacterial colonisation levels during infection were monitored by
stool sampling, and mucosal immune responses to infection were
evaluated through quantification of immune cell influxes into the
lamina propria, measurement of the extent of hyperplasia and
quantification of cytokine and chemokine levels in the distal colon.
The immune responses of Lgals12/2 and Lgals32/2 mice to
infection are presented separately for clarity.
Gal-3 deficient mice showed altered colonisation to C.
rodentium infection
Gal-3 null mice and wild-type controls (C57BL/6) were orally
inoculated with C. rodentium and the number of bacteria shed per
Gal-1 and Gal-3 in C. rodentium Infection
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gram of stool was used to monitor mucosal colonisation
(Figure 1A). Wild-type mice showed typical colonisation kinetics
with infection peaking at approximately 56108 cfu/g stool
between days 5 and 9 post inoculation (p.i.), followed by reducing
numbers from day 12 onwards as the bacteria are cleared from the
gastrointestinal tract. The Lgals32/2 mice demonstrated a
decreased early colonisation at day 2 and day 5 p.i. (Figure 1B).
Although infection peaked at around the same level as wild-type
mice from day 7 to 12 p.i., Gal-3 deficient mice shed significantly
more bacteria between days 12 and 15, indicating a slightly altered
kinetics of infection (Figure 1B). All Lgals32/2 mice showed a
logarithmic decrease in stool shedding at day 15, showing
resolution of infection. Although the pathogen burden at day
15 p.i. was significantly greater in Gal-3 null mice, the colonic
mucosal hyperplasia characteristic of C. rodentium infection was
not significantly different to that of wild-type (Figure 1C).
Lgals32/2 mice showed reduced immune cell infiltration
into colonic tissue during C. rodentium infection
Since Gal-3 is known to promote the migration and survival of
T cells, dendritic cells (DC), macrophages and neutrophils
[4,10,18,22,23], a reduction in inflammatory responses might
explain the observed slight delay in bacterial clearance in the Gal-
3 deficient mice. C. rodentium infection typically elicits an influx of
CD4+ and CD8+ T cells, DC, macrophages and neutrophils
[19,22]. Uninfected Lgals32/2 and wild type mice showed similar
immune cell counts in the lamina propria (data not shown).
Infection with C. rodentium induced a significant increase in the
Figure 1. Galectin-3 deficient mice showed delayed colonisation and clearance, and normal crypt hyperplasia after C.rodentium
infection. A. Scheme of the protocol used for infection and sampling; B. The colony forming units (cfu) of C. rodentium shed per gram of stool by
infected C57BL/6 wild-type controls (open circles) and infected Galectin-3 knockout (Lgals32/2) mice (closed circles) is shown per day after infection.
Values indicate the median and interquartile range of groups of 11 animals; C. Crypt length at day 15 post infection. Dots indicate the average crypt
length per mouse, while horizontal lines indicate the average per group of mice (n = 2–4 for uninfected mice and 9–11 for infected mice). Data was
obtained from 2 independent infection experiments, an asterisk indicates a statistically significant difference (p,0.02) and ‘‘ns’’ means no significant
difference (p.0.05) between Lgals32/2 and C57BL/6 wild-type controls.
doi:10.1371/journal.pone.0107933.g001
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number of lamina propria CD3+ T cells, CD4+ T cells, CD8+ T
cells, DC and macrophages at day 15 p.i. in wild-type mice.
However, in agreement with the pro-inflammatory functions of
Gal-3, Lgals32/2mice showed a significantly reduced immune cell
influx compared to C. rodentium infected wild-type controls
(Figure 2A). There was no however effect on the influx of
endogenous peroxidase-containing (EPC) cells (most commonly
neutrophils) into the lamina propria (Figure 2A).
C. rodentium infected Lgals32/2 mice showed increased
expression of IL-6
We next quantified the pro-inflammatory cytokines interferon
gamma (IFN-c), tumor necrosis factor alpha (TNF-a), interleukin
(IL)-1b, and IL-6, and the anti-inflammatory cytokine IL-10, in
infected colonic tissue by ELISA. The neutrophil chemoattractant
keratinocyte-derived chemokine (KC) was also quantified. Control
mice showed undetectable levels of these proteins in the
gastrointestinal tract prior to infection (data not shown). C.
rodentium infected Lgals32/2 mice showed TNF-a, IFN-c and IL-
1b levels similar to wild-type controls at day 15 p.i. (Figure 2B).
IL-10 was present at low levels and was not significantly different
between Lgals32/2 mice and wild-type controls (Figure 2B).
Interestingly IL-6, which has been implicated in protection of
the epithelium during C. rodentium infection [23], was signifi-
cantly increased in mutant mice compared with wild-type controls
at day 15 p.i. (Figure 2B). KC was also significantly increased
compared to infected wild-type controls (Figure 2B) but, as shown
in figure 3A, there was no increase in the number of neutrophils in
the lamina propria at day 15 p.i.
Galectin-1 deficiency has no effect on C. rodentium
infection kinetics or hyperplasia
Next we investigated the effect of deficiency in the anti-
inflammatory lectin Gal-1 in Lgals12/2 mice infected with C.
rodentium (Figure 3A). These mice demonstrated colonisation
kinetics that closely followed wild-type infection (Figure 3B),
suggesting that Gal-1 does not play a role in immunity to C.
rodentium infection. Uninfected Lgals12/2 mice exhibited normal
crypt architecture (Figure 3C) and the colonic mucosal hyperpla-
sia induced by C. rodentium infection was not significantly
different from that of wild-type at day 15 p.i. (Figure 3C).
Lgals12/2 mice showed reduced T cell and enhanced
neutrophil infiltrates into colonic tissue during C.
rodentium infection
T cell infiltrates in the lamina propria of Lgals12/2 mice were
investigated by immunohistochemistry. On infection with C.
rodentium, Lgals12/2 mice showed a significant decrease in the
number of CD3+, CD4+ and CD8+ T cells compared to uninfected
control mice at day 15 p.i. (Figure 4A). Conversely, Lgals12/2
mice exhibited greater number of EPC cells in the colonic lamina
propria at day 15 p.i. than wild-type controls (Figure 4A). The
reduced lamina propria T cell infiltrate of C. rodentium infected
Lgals12/2 mice (Figure 4A) was similar to that observed in
infected Lgals32/2 mice (Figure 2A).
C. rodentium infected Lgals12/2 mice showed increased
expression of IL-6 and KC similar to Lgals32/2 mice
Cytokines were quantified in the colonic tissue of C. rodentium
infected Lgals12/2 mice and we found that the content of TNF-a,
IFN-c, IL-1b and IL-10 were statistically similar to infected wild-
type control animals (Figure 4B). Interestingly, the pro-inflamma-
tory cytokine IL-6 and the neutrophil chemoattractant KC were
increased in Lgals12/2 mice, as it was observed in Lgals32/2 mice
(Figure 2B). Although the increased level of KC in Lgals12/2 mice
was no statistically significant (Figure 4A), the trend may be
consistent with significant increase of EPC cells in the colon of
infected Lgals12/2 mice (Figure 4B).
Galectin-1 induced the migration of monocytes in vitro
Since Lgals12/2 mice had significantly fewer lamina propria
resident macrophages than wild-type mice, and these mice did not
demonstrate a macrophage response to infection with C.
rodentium, we hypothesised that Gal-1 might have chemoattrac-
tant function for the monocytic precursors of lamina propria
macrophages. To test this hypothesis, we used the murine
monocytic cell line J774 in a transwell system to quantify the
Figure 2. Galectin-3 deficient mice showed reduced inflamma-
tory infiltrates into lamina propria and enhanced expression of
IL-6 and KC. A. Number of CD3+ cells, CD4+ cells, CD8+ cells,
macrophages (MW), dendritic cells (DC) and endogenous peroxidase-
containing (EPC) cells or neutrophils per 250 mm2 of colonic lamina
propria in C. rodentium infected mice. Bars indicate the average for each
group of 10 C57BL/6 wild-type and Lgals32/2 animals; B. Data show
cytokine and chemokines levels as pg per mg of total proteins in the
colonic tissue of Lgals32/2 and C57BL/6 wild-type control mice. Data fit
Gaussian distribution, bars represent the mean cytokine expression for
groups of 10 mice while error bars indicate the SEM. Data was obtained
from 2 independent infection experiments. An asterisk indicates a
statistically significant difference (p#0.05) and ‘‘ns’’ means no
significant difference (p.0.05) between groups of galectin deficient
and control mice.
doi:10.1371/journal.pone.0107933.g002
Gal-1 and Gal-3 in C. rodentium Infection
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migratory activity of Gal-1 compared to the known MCP-1. We
found that Gal-1 significantly induced the migration of monocytes,
similarly to MCP-1 (Figure 5), suggesting that Gal-1 might act as a
mucosal chemoattractant for monocytes in vivo.
Discussion
We investigated the importance of galectins in immunity to
bacterial pathogens at the gastrointestinal surface in a mouse
model of infection with C. rodentium. Although Gal-3 deficiency
has been reported to have no effect on resolution of Trichuris
muris nematode infection [24], in this work Lgals32/2 mice
demonstrated a significant delay in clearance of the non-invasive
bacterial pathogen C. rodentium following the oral administration,
which is associated with a significant reduction in the recruitment
of T cells, DC and macrophages to the lamina propria of the
colon, which likely promoted a delayed clearance of this pathogen
in vivo. Our data therefore supports previous experiments
demonstrating that Gal-3 deficient mice have defects in immune
cell recruitment and maintenance at inflamed sites and supports
the hypothesis that Gal-3 exerts a mucosal pro-inflammatory effect
in vivo on T cells [3,4,25], macrophages and DC [1,26,27].
Therefore, for the first time Gal-3 deficiency has been shown to
result in delayed clearance of a pathogen. Although Toxoplasma
gondii infection of Gal-3 null mice resulted in increased pathogen
burdens in the lungs and brain and reduced leukocyte recruitment,
the infection was resolved normally, probably due to enhanced
Th1 responses with heightened IFN-c expression and a high
serum IgG2a:IgG1 ratio [3]. In another study, Gal-3 null mice
infected with Schistosoma mansoni also demonstrated reduced
Figure 3. Galectin-1 deficient mice showed infection kinetics similar to wild-type controls and normal hyperplasia levels. A. Scheme
of the protocol used for infection and sampling; B. Data represent colony forming units (cfu) of C. rodentium shed per gram of stool by infected
C57BL/6 wild-type controls (open circles) and infected Galectin-1 knockout (Lgals12/2) mice (closed circles) at different stages of the infection plan.
Dots indicate the median and interquartile range of groups of 10 animals; C. Crypt length at day 15 post infection is plotted. Dots indicate the
average crypt length per mouse, while horizontal lines indicate the average per group of mice (n = 2–4 for uninfected mice and 9–11 for infected
mice). Data was obtained from 2 independent infection experiments, ‘‘ns’’ means no significant difference (p.0.05) between infected galectin
deficient and wild-type mice.
doi:10.1371/journal.pone.0107933.g003
Gal-1 and Gal-3 in C. rodentium Infection
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immune cell recruitment and a Th1-biased immune response,
which resulted in reduced liver granuloma formation. However,
no differences in parasite burden nor resolution of infection was
observed between deficient and wild-type mice [25]. In addition,
we observed that Lgals32/2 mice showed a considerable delay in
intestinal colonisation after oral challenge with C. rodentium.
Since Gal-3 is located at the apical surface of confluent colonic
T84 cells [28], it is exclusively secreted from the apical surface of
polarised kidney epithelial cells [29], it is produced by colonic
epithelial cells closely located to the luminal surface and it is
attached to mucin [30], [31], we propose that Gal-3 might
constitute a binding target for C. rodentium and a deficiency in this
lectin might negatively affect the ability of C. rodentium to colonize
the intestinal mucosa. Other works have demonstrated that Gal-3
aggregates are coating indigenous bacteria in the gastrointestinal
tract of mice and Gal-3 can bind directly to b-galactoside-
containing membrane lipopolysaccharide (LPS) from Klebsiella
pneumoniae [32], Salmonella Minnesota, Salmonella typhimurium,
Neisseria gonorrhoeae and Helicobacter pylori [15,33,34]. Indeed,
over expression of Gal-3 in gastric epithelial cells results in
enhanced adhesion of H. pylori to cells in vitro [15]. Preliminary
data from confocal microscopy and ELISA experiments indicate
that C. rodentium might express a Gal-3-like surface protein as
well as Gal-3 receptors (unpublished data). However, additional
components may be involved in the colonisation of this bacteria to
the mucosa surface since similar colonic burdens were reached in
Gal-3 deficient mice and wild-type controls, and the infection
process was not shortened by a deficiency in Gal-3. Likewise,
demonstrated that although H. pylori could bind to Gal-3, this
binding was not the only adherence mechanism employed by the
pathogen during colonisation of gastric epithelial cells in vitro [15].
Contrary to previous works demonstrating reduced neutrophil
recruitment in Gal-3 deficient mice in the lung mucosa during
streptococcal infection and into the peritoneal cavity during T.
gondii challenge [3,17], we did not observe a reduction in lamina
propria neutrophil recruitment during C. rodentium infection.
Instead, Lgals32/2 mice demonstrated KC expression 10 times
higher than infected controls. This data might suggest that Gal-3
deficiency might affect the ability of neutrophils to respond to the
KC chemokine, possibly due to reduced neutrophil adhesion to
endothelial cells and ECM proteins, functions normally enhanced
by the actions of Gal-3 [18,35].
Regarding Gal-1, although this lectin is a cervical epithelial cell
receptor for the sexually transmitted parasite Trichomonas
vaginalis and can promote HIV-1 absorption to CD4+ T cells
and macrophages facilitating the infection [36,37], in this work we
observed no effect on C. rodentium colonisation of the mucosal
epithelium.
Unexpectedly, we found that Lgals12/2 mice had diminished T
cells and macrophages in the colonic lamina propria during
infection with C. rodentium as compared to wild type mice and
similarly to Lgals32/2 mice. Therefore, the deficiency in Gal-1 or
Gal-3 resulted in a similar reduction in the T cell influx into the
lamina propria on infection, which might suggest these lectins have
Figure 4. Galectin-1 deficient mice showed increased neutro-
phil and DC infiltrates and enhanced expression of IL-6 and KC.
A. Number of CD3+ cells, CD4+ cells, CD8+ cells, macrophages (MW),
endogenous peroxidase-containing (EPC) cells (most commonly neu-
trophils) and DC (dendritic cells) per 250 mm2 of colonic lamina propria
in C. rodentium infected mice. Bars indicate the average for each group
of 10 C57BL/6 wild-type and Lgals12/2 animals; B. Data show cytokines
and chemokine levels as pg per mg of total proteins in the colonic
tissue of Lgals12/2 and C57BL/6 wild-type control mice. Data fit
Gaussian distribution, bars represent the mean expression for groups of
10 mice while error bars indicate the SEM. Data was obtained from 2
independent infection experiments, an asterisk indicates a statistically
significant difference (p#0.05) and ‘‘ns’’ means no significant difference
(p.0.05) between galectin and wild-type control mice.
doi:10.1371/journal.pone.0107933.g004
Figure 5. Galectin-1 induces migration of J774 monocytes in
vitro. Number of J774 monocytes that cross a transwell membrane
when stimulated with 100 ng/ml monocyte chemoattractant protein
(MCP-1, black squares), 100 ng/ml Gal-1 (grey circles) or 1 mg/ml Gal-1
(black circles) for 6, 12 and 24 hours. Each symbol represents the mean
and SEM from 3 experiments in which 5 counts per membrane were
taken by 2 independent researchers. An asterisk indicates a statistically
significant difference (p,0.05) between Gal-1 treated wells and media
only controls.
doi:10.1371/journal.pone.0107933.g005
Gal-1 and Gal-3 in C. rodentium Infection
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a similar but non-redundant function with regards to T cell
responses. A reduction in macrophage and DC antigen presentation
might account for the reduced T cell responses in Lgals32/2 mice,
whereas profound macrophage deficiency or the loss of a
macrophage derived factor might account for the T cell responses
observed in Lgals12/2mice. Interestingly, Gal-1 deficient mice had
very few lamina propria macrophages prior to infection, and failed
to mount a macrophage response to infection, at least at the time
point considered. This prompted us to hypothesise that Gal-1 might
play a role in the recruitment of the monocytic precursors of
macrophages to the colonic epithelium. Indeed, the transwell assays
led us demonstrate that Gal-1 induced migration of the monocytic
cell line J774 in vitro. This data is supported by the work of Malik
et.al [38]. Despite evidences that monocytes can differentiate into
both DC and macrophage [39,40], we found higher amount of DC
in the lamina propria of Gal-1 deficient mice, which might suggest
that monocyte recruitment is not affected by Gal-1 deficiency.
The enhanced recruitment of DC and neutrophils in the lamina
propria might be responsible for the normal resolution of infection.
These data support the hypothesis that Gal-1 has anti-inflamma-
tory functions in vivo and might act to limit the recruitment of DC
and neutrophils to sites of inflammation. Indeed, previous work
has demonstrated that Gal-1 can directly inhibit DC migration to
draining lymph nodes in vivo, it can inhibit neutrophil adhesion
and migration and enhances neutrophil phagocytosis by macro-
phages [41–45].
The loss of these Gal-1 mediated inhibitory functions might
explain the enhanced DC and neutrophil responses observed in C.
rodentium infected Gal-1 deficient mice.
Although our in vivo data supports some of the proposed pro-
inflammatory functions of Gal-3 and anti-inflammatory functions
of Gal-1, we found surprising similarities in the responses of
Lgals32/2 and Lgals12/2 mice to C. rodentium infection.
Hyperplasia was normal in both groups of mice, perhaps as a
result of heightened IL-6 production which acts to protect the
epithelium from apoptosis during C. rodentium infection to
maintain barrier function [23]. Both deficient mice showed
similarly reduced CD3+ T cell responses, reduced macrophage
responses, unchanged IL-10, IL-1b, TNF-a and IFN-c cytokine
responses and increased KC chemokine expression, although
Lgals32/2 mice showed significantly more expression of these
cytokines and chemokines than Lgals12/2 mice. Taken together,
these data might suggest that Gal-1 and Gal-3 are not as opposed
in function as previously hypothesised.
In conclusion, we have demonstrated that Gal-3 plays an
important role in the mucosal immune response to infection with
the bacterial pathogen C. rodentium and might constitute a
binding partner for C. rodentium in vivo. Gal-1 also plays a role in
gastrointestinal immune responses to bacterial infection, particu-
larly with regard to T cell and macrophage responses, but can be
compensated to maintain normal colonisation and infection
resolution.
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